Accuro is improving patient care and administrative efficiency in low-resource settings. Anesthesiologist Dr. Audrey Alleyne discusses the tremendous benefits of the Accuro Neuraxial Guidance device for spinal and epidural anesthesia where time and access to ultrasounds are otherwise limited.
Recent Posts
- RIVANNA Receives FDA 510(k) Clearance for Accuro XV Musculoskeletal Ultrasound Imaging System
- RIVANNA nominated for MedTech Scale-Up of the Year at MedTech World Awards 2026 | North America
- RIVANNA’s Accuro XV Demonstrates Feasibility of Musculoskeletal Imaging by Non-physician Users With Minimal Training
- RIVANNA expands multi-site clinical study for Accuro XV musculoskeletal imaging system
- Neuraxial Anesthesia: What is State of the Art in 2026?
